Most Recent

  • 27 Sep 2012

Benefits of a Modern Court Case Management System

A well-designed CMS brings benefits to the courts, such as more efficient data entry, more effective data retrieval, better tools and enhanced bar and public access.

  • 13 Aug 2012

Trending Now Series: Form PF

A hot topic briefing addressing the key challenges and opportunities facing private fund advisors as they endeavor to meet their new regulatory obligations.

  • 01 Aug 2012

Legal Entity Data: Mapping The Corporate Genome

This white paper gives an overview of where the LEI initiative now stands and its associated background.

Recommended

Market Abuse Regulation of the Commodities and Energy Markets

This research paper identifies and summarises the existing and future regulations that continue to tighten the obligations of firms operating in the Commodities and Energy markets in the US and Europe.

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.

Recommended

Most Recent

  • 13 Aug 2012

Trending Now Series: Form PF

A hot topic briefing addressing the key challenges and opportunities facing private fund advisors as they endeavor to meet their new regulatory obligations.

  • 01 Aug 2012

Legal Entity Data: Mapping The Corporate Genome

This white paper gives an overview of where the LEI initiative now stands and its associated background.

  • 02 Jul 2012

The Practical Aspects in Delivering a European Consolidated Tape

This position paper describes and explores how post MiFID consolidated tape data could be useful, what the proposed CTP would entail, as well as providing a comparison to the US consolidated tape.

Recommended

Market Abuse Regulation of the Commodities and Energy Markets

This research paper identifies and summarises the existing and future regulations that continue to tighten the obligations of firms operating in the Commodities and Energy markets in the US and Europe.

Most Recent

  • 13 Mar 2011

Newport Whitepapers

Our latest white papers from Newport on Deals, Biologics, Japanese Generics and 5 Myths.

  • 07 Mar 2011

New Study on Scientific Progress in Middle East

Turkey, Iran, Egypt, Saudi Arabia and Jordan currently account for 90 percent of the region's output.

  • 16 Nov 2010

High-Risk, High-Reward

Our new report on Asia Pacific Pharma companies' R&D; activity.

  • 12 Aug 2009

Outlook and Issues for the Biotechnology Sector

A comprehensive assessment of Wall Street’s perception of and outlook for the biotechnology sector. This analysis aims to provide companies with an insider’s perspective on what the investment community values in the current economic climate, including cash position, pipeline, regulatory environment, upcoming catalysts, and IR communications, among others.

Recommended

Who's Making the Biggest Splash?

Expert, measured insight into organizations that helped to shape professional opinions on drugs and therapies, using the unique insights of the Thomson Reuters Medical Literature AnalyzerSM.